Google recently filed a US patent for embedding tiny microscopic cameras into contact lenses. It is interesting to see how innovative businesses and inventors are exploring unique applications for contact lenses. We will, in...

Swiss giant Novartis has dragged Biocon to Delhi High Court for allegedly infringing patent rights of its diabetes drug “Galvus” and now Biocon cannot manufacture, sell or export vildagliptin until the next hearing. The multinational is seeking an injunction...

Touted to be among “the biggest breakthroughs in medicine in the last 10 years”, Sofosbuvir (brand name Sovaldi) was approved on December 6, 2013 by the U.S. Food and Drug Administration (FDA) as a new treatment...

Indian Patent Office recently published Patent (Amendment) Rules, 2014 and it includes few major updates that anyone applying for patents in India must be aware of. Following are the major ones that will really...

Google’s $3.2 billion acquisition of smart thermostat company, Nest Labs which also is its second biggest ever is certain to fortify company’s place in terms of intellectual property. Google had been weak on patents...

In 2006, the Indian patent office had rejected the patent application for Novartis cancer drug, “Glivec” on grounds that – –    The original molecule imatinib was in public domain before 1995—the cut-off year...

The Indian Patent Office (IPO) has issued new draft guidelines for pharmaceutical patents.  “Enhanced Therapeutic Efficacy” Replaces The Earlier Phrase “Enhanced Efficacy”: Becomes The Only Criteria For Grant Of A New Patent For Drug...

In the area of “Intellectual Property”, a patent applicant is required to obtain a written Foreign Filing License FFL permit from the national patent office prior to applying for a foreign patent. When FFL...

The idea behind patent opposition is to restrain wrongful patent grants and claims of the petty inventions. So, under Indian Patent act, depending upon the stage of the patent, there are two provisions when...